Cite
MLA Citation
Dustin Freshwater et al.. “To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)?.” Open forum infectious diseases, vol. 4, n.d., pp. S337–S338. http://access.bl.uk/ark:/81055/vdc_100151518780.0x00002f